The author missed that Cardiocel showed no evidence of calcification after 7 years and I think this brings into question the motivations of the author, especially given they had a chance to clarify in their second response.
As someone previously pointed out, they couldn't spell Cardiocel properly so the article can't be taken seriously.
I think most holders see the vaccine side as speculative. The appeal of this stock is it's ability to generate revenue whilst also having that speculative side of it.
The author missed that Cardiocel showed no evidence of...
-
- There are more pages in this discussion • 168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.010(0.10%) |
Mkt cap ! $213.7M | |||
| Open | High | Low | Value | Volume |
| $10.20 | $10.26 | $9.81 | $396.9K | 39.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1200 | $10.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 966 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |